Symptomless infection with Ebola virus.
Baxter
A G
AG
Centenary Institute of Cancer Medicine and Cell Biology, Newtown NSW, Australia.
D000350:Africa, Central; D000914:Antibodies, Viral / Q000097:blood; D029043:Ebolavirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D019142:Hemorrhagic Fever, Ebola / Q000175:diagnosis* / Q000276:immunology / Q000635:transmission; D006801:Humans; D018836:Inflammation Mediators / Q000276:immunology; D007375:Interleukin-1 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D014779:Virus Replication
D000914:Antibodies, Viral; D018836:Inflammation Mediators; D007375:Interleukin-1; D015850:Interleukin-6; D012367:RNA, Viral; D014409:Tumor Necrosis Factor-alpha